Researchers hunt for clues to improve colorectal cancer Drug's success
NCT ID NCT07124858
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 300 adults with advanced colorectal cancer who are taking the drug fruquintinib. Researchers want to find out which patient or tumor features help the drug work best and improve survival. The goal is to learn from real-world use to better match patients with effective treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Dec 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 and over. * Histologically confirmed colorectal adenocarcinoma with locally advanced disease and/or unresectable metastasis(es) receiving treatment with fruquintinib under i) compassionate/early access and ii) marketing authorisation and reimbursement in France. * Obtain informed consent from the patient for the clinical-biological cohort. * Agreement to take biological samples of ctDNA and send tumour blocks (patient participation in the pharmacokinetic study remains optional). Exclusion Criteria: * Patient with another concurrent cancer at the time of diagnosis, requiring systemic treatment or influencing prognosis (in the opinion of the centre's medical team). * Contraindication due to psychological or social reasons that may hinder follow-up (cognitive deficit, psychological disorders incompatible with obtaining consent; inability to be followed in the same centre throughout the follow-up period for geographical reasons). * Pregnant or breast-feeding women. * Patients under court protection or subject to a protective measure (patient under guardianship or curatorship).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Antineoplastic agents, immunological are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
83 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BICHAT
RECRUITINGParis, France
-
CH de la source
RECRUITINGOrléans, France
-
CHI
RECRUITINGFréjus, France
-
CHU
RECRUITINGAmiens, France
-
CHU
RECRUITINGBesançon, France
-
CHU
RECRUITINGBrest, France
-
CHU
RECRUITINGCaen, France
-
CHU
RECRUITINGLille, France
-
CHU
RECRUITINGLimoges, France
-
CHU
RECRUITINGPessac, France
-
CHU
RECRUITINGPoitiers, France
-
CHU
RECRUITINGReims, France
-
CHU
RECRUITINGRennes, France
-
CHU
RECRUITINGRouen, France
-
CHU
RECRUITINGTours, France
-
CHU
RECRUITINGVandœuvre-lès-Nancy, France
-
COCHIN
RECRUITINGParis, France
-
Centre Cario
RECRUITINGPlérin, France
-
Centre Hospitalier
RECRUITINGAlbi, France
-
Centre Hospitalier
RECRUITINGAnnecy, France
-
Centre Hospitalier
RECRUITINGAurillac, France
-
Centre Hospitalier
RECRUITINGBayeux, France
-
Centre Hospitalier
RECRUITINGBayonne, France
-
Centre Hospitalier
RECRUITINGBeauvais, France
-
Centre Hospitalier
RECRUITINGCalais, France
-
Centre Hospitalier
RECRUITINGChartres, France
-
Centre Hospitalier
RECRUITINGCholet, France
-
Centre Hospitalier
RECRUITINGFlers, France
-
Centre Hospitalier
RECRUITINGLe Puy-en-Velay, France
Contact Email: •••••@•••••
-
Centre Hospitalier
RECRUITINGLens, France
-
Centre Hospitalier
RECRUITINGNiort, France
-
Centre Hospitalier
RECRUITINGPau, France
-
Centre Hospitalier
RECRUITINGPerpignan, France
-
Centre Hospitalier
RECRUITINGSaint-Denis, France
-
Centre Hospitalier
RECRUITINGSoissons, France
-
Centre Hospitalier
RECRUITINGSt-Malo, France
-
Centre Hospitalier
RECRUITINGThonon-les-Bains, France
-
Centre Hospitalier
RECRUITINGVersailles, France
-
Centre Hospitalier Bethune Beuvry
RECRUITINGBeuvry, France
-
Centre Hospitalier Henri Mondor
RECRUITINGCréteil, France
-
Centre Hospitalier Sud Francilien
RECRUITINGCorbeil-Essonnes, France
-
Centre Hospitalier de Vendee
RECRUITINGLa Roche-sur-Yon, France
-
Centre Leonard de Vinci
RECRUITINGDechy, France
-
Centre Pierre Curie
RECRUITINGBeuvry, France
-
Ch Du Mittan
RECRUITINGMontbéliard, France
-
Chu Francois Mitterand
RECRUITINGDijon, France
-
Chu Rangueil
RECRUITINGToulouse, France
-
Clinique Ambroise Pare Hartmann
RECRUITINGNeuilly, France
-
Clinique Branche - Clinique Flandres
RECRUITINGCoudekerque-Branche, France
-
Clinique Gray
RECRUITINGMaubeuge, France
-
Clinique Jean Mermoz
RECRUITINGLyon, France
-
Clinique Sainte Anne
RECRUITINGStrasbourg, France
-
Clinique Sainte Clothilde
RECRUITINGLa Réunion, France
-
Clinique Sainte Come
RECRUITINGCompiègne, France
-
Clinique Sainte Marie
RECRUITINGChalon-sur-Saône, France
-
Clinique Tivoli
RECRUITINGBordeaux, France
-
Clinique de L Europe
RECRUITINGAmiens, France
-
Groupe Hospitalier Diaconesses Croix Saint Simon
RECRUITINGParis, France
-
Groupe Hospitalier Mutualiste
RECRUITINGGrenoble, France
-
Groupement Hospitalier Bretagne Sud
RECRUITINGLorient, France
-
Hopital Americain
RECRUITINGNeuilly-sur-Seine, France
-
Hopital Avicenne
RECRUITINGParis, France
-
Hopital Europeen
RECRUITINGMarseille, France
-
Hopital Instruction Des Armees
RECRUITINGPercy, France
-
Hopital Nord Ouest
RECRUITINGVillefranche-sur-Saône, France
-
Hopital Prive Confluent
RECRUITINGNantes, France
-
Hopital Prive Drome Ardeche
RECRUITINGValence, France
-
Hopital Prive Forcilles
RECRUITINGFérolles-Attilly, France
Contact Email: •••••@•••••
-
Hopital Prive de L Estuaire
RECRUITINGLe Havre, France
-
Hopital Saint Joseph
RECRUITINGMarseille, France
-
Hopital Saint Louis
RECRUITINGParis, France
-
Infirmerie Protestante
RECRUITINGCaluire-et-Cuire, France
-
Institut de Cancerologie de Bourgogne
RECRUITINGDijon, France
-
Institut de Cancerologie de Lorraine
RECRUITINGNancy, France
-
La Pitie Salepetriere
RECRUITINGParis, France
-
La Timone
RECRUITINGMarseille, France
-
Lyon Sud
RECRUITINGPierre-Bénite, France
-
Medipole Hopital Mutualiste
RECRUITINGVilleurbanne, France
-
Poitiers CHU
RECRUITINGPoitiers, France, 86021, France
-
Polyclinique de Blois
RECRUITINGLa Chaussée-Saint-Victor, France
-
Polynclinique Bordeaux Nord Aquitaine
RECRUITINGBordeaux, France
-
ROC37
RECRUITINGChambray-lès-Tours, France
-
Saint Antoine
RECRUITINGParis, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Replacing the whole liver: a radical bid to outlast colorectal cancer
- Can a pill target a Hard-to-Treat colorectal cancer?
- Can a new pill plus cetuximab outsmart Hard-to-Treat colorectal cancer?
- Can radiation plus two immunotherapies shrink Hard-to-Treat tumors?
- Can mindfulness together ease the burden of advanced cancer?
- Can a Two-Pronged attack shrink Hard-to-Treat colorectal tumors?